@article{93b37020f3c442a18b31a86cd00b6857,
title = "CAGE-defined promoter regions of the genes implicated in Rett Syndrome",
abstract = "Background: Mutations in three functionally diverse genes cause Rett Syndrome. Although the functions of Forkhead box G1 (FOXG1), Methyl CpG binding protein 2 (MECP2) and Cyclin-dependent kinase-like 5 (CDKL5) have been studied individually, not much is known about their relation to each other with respect to expression levels and regulatory regions. Here we analyzed data from hundreds of mouse and human samples included in the FANTOM5 project, to identify transcript initiation sites, expression levels, expression correlations and regulatory regions of the three genes. Results: Our investigations reveal the predominantly used transcription start sites (TSSs) for each gene including novel transcription start sites for FOXG1. We show that FOXG1 expression is poorly correlated with the expression of MECP2 and CDKL5. We identify promoter shapes for each TSS, the predicted location of enhancers for each gene and the common transcription factors likely to regulate the three genes. Our data imply Polycomb Repressive Complex 2 (PRC2) mediated silencing of Foxg1 in cerebellum. Conclusions: Our analyses provide a comprehensive picture of the regulatory regions of the three genes involved in Rett Syndrome.",
keywords = "CAGE, Promoter architecture, Rett Syndrome, Transcriptomics",
author = "{The FANTOM Consortium} and Morana Vitezic and Nicolas Bertin and Robin Andersson and Leonard Lipovich and Hideya Kawaji and Timo Lassmann and Albin Sandelin and Peter Heutink and Dan Goldowitz and Thomas Ha and Peter Zhang and Annarita Patrizi and Michela Fagiolini and Forrest, {Alistair R.R.} and Piero Carninci and Alka Saxena",
note = "Funding Information: FANTOM5 was funded by a Research Grant for RIKEN Omics Science Center from MEXT to Yoshihide Hayashizaki and a Grant for Innovative Cell Biology by Innovative Technology (Cell Innovation Program) from MEXT, to YH, by a grant from MEXT to RIKEN Center for Life Science Technologies and by a grant from MEXT to RIKEN Preventive Medicine and Diagnosis Innovation Program. MV is supported by an International Program Associate scholarship from RIKEN and a grant from the Frankopani Fund. RA and AS, as well as MV{\textquoteright}s work in AS group, was funded by the Lundbeck and Novo Nordisk Foundations, and the RiMod-FTD JPND EU joint program. Work by DG, PZ, and TH was funded by Genome BC and NSERC. MF is supported by SFARI Simons Foundation, AP is supported by Rett Syndrome Foundation. A.Saxena is supported by a Funding program for next generation world leading Researchers by MEXT, HFSP (RGP0014/2012) to PC, a JSPS International Fellowship (P09745) and currently by the National Institute of Health Research funded Biomedical Research Centre at Guy{\textquoteright}s and St. Thomas{\textquoteright} Trust, London, UK. Publisher Copyright: {\textcopyright} 2014 Vitezic et al.",
year = "2014",
month = dec,
day = "24",
doi = "10.1186/1471-2164-15-1177",
language = "English",
volume = "15",
pages = "1--16",
journal = "BMC Genomics",
issn = "1471-2164",
publisher = "BioMed Central",
number = "1",
}